Pressmeddelande

SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Malaysia

Cision Publicerad: 06 Sep 2022 09:00

SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory approval in Malaysia and can now be sold and distributed in this market.

“We are very excited to bring our innovative SyMRI software to the Malaysian market,” says Deepak Sharma, Head of Sales in India and South East Asia. “Our entrance into this market opens the door to many incredible opportunities for SyntheticMR. We are looking forward to working with new healthcare providers to support a faster hospital workflow, greater diagnostic confidence, and improved patient satisfaction.”

SyMRI provides multiple contrast weighted images and quantitative information about the patient in a single 5-minute scan, enabling users to speed up their imaging workflow and add objective decision support to their practice.

Bifogade filer

Releasehttps://mb.cision.com/Main/11663/3599802/1623126.pdf

Nyheter om SyntheticMR

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!